GEN Exclusives

More »

GEN Poll

More »
Nov 06, 2012

Blockbuster Drugs: Endangered Species?

Our list of top-selling drugs of the 21st century shows how much money those drugs made between 2000 and 2011; the total amounts for all of them are in the billions. However, given the advent of personalized medicine and the increasing number of biosimilars entering the market, will pharmaceutical giants be able to maintain that level of success, or does our list contain the last of the blockbusters?

Have we seen the last of the blockbuster drugs?


Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »